HIV & AIDS

HIV lessons from the Mississippi Baby

(Medical Xpress)—The news in July that HIV had returned in a Mississippi toddler after a two-year treatment-free remission dashed the hopes of clinicians, HIV researchers and the public at large tantalized by the possibility ...

HIV & AIDS

Climate change reduces HIV treatment adherence in Africa

Droughts caused by climate change can have an impact on HIV treatment, according to a new study led by researchers at Brighton and Sussex Medical School (BSMS), Africa Health Research Institute (AHRI) and the University of ...

HIV & AIDS

Pitt study points to new opportunities for HIV treatment

Sometimes in science, answers come serendipitously, where researchers aren't expecting to find them. That's what happened to Cristian Apetrei, Ivona Pandrea and their colleagues during a recent study on human immunodeficiency ...

HIV & AIDS

Drug stops HIV among hetero couples, not just gays

An AIDS drug already shown to help prevent spread of the virus in gay men also works for heterosexual men and women, two studies in Africa found. Experts called it a breakthrough for the continent that has suffered most from ...

HIV & AIDS

Four decades on, where's the HIV vaccine?

In the four decades since the first cases of what would come to be known as AIDS were documented, scientists have made huge strides in HIV treatment, transforming what was once a death sentence to a manageable condition.

HIV & AIDS

'Mississippi Baby' now has detectable HIV, researchers find

The child known as the "Mississippi baby"—an infant seemingly cured of HIV that was reported as a case study of a prolonged remission of HIV infection in The New England Journal of Medicine last fall—now has detectable ...

HIV & AIDS

10-year lifespan gain for some HIV patients: study

The life expectancy of HIV-infected people in Europe and the United States has been boosted by a decade since anti-AIDS drugs became available in the mid-1990s, researchers said Thursday.

page 4 from 39